vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and EZCORP INC (EZPW). Click either name above to swap in a different company.

EZCORP INC is the larger business by last-quarter revenue ($382.0M vs $284.0M, roughly 1.3× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 11.6%, a 84.7% gap on every dollar of revenue. On growth, EZCORP INC posted the faster year-over-year revenue change (19.3% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 15.6%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

EZCORP, Inc. is an American pawn shop operator based in Austin, Texas which provides services across the United States and Latin America. It is a publicly traded company listed on the NASDAQ stock exchange and is the second largest pawn shop operator in the U.S. after Cash America International.

ACAD vs EZPW — Head-to-Head

Bigger by revenue
EZPW
EZPW
1.3× larger
EZPW
$382.0M
$284.0M
ACAD
Growing faster (revenue YoY)
EZPW
EZPW
+9.9% gap
EZPW
19.3%
9.4%
ACAD
Higher net margin
ACAD
ACAD
84.7% more per $
ACAD
96.3%
11.6%
EZPW
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
17.5%
15.6%
EZPW

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ACAD
ACAD
EZPW
EZPW
Revenue
$284.0M
$382.0M
Net Profit
$273.6M
$44.3M
Gross Margin
90.8%
58.4%
Operating Margin
6.1%
15.9%
Net Margin
96.3%
11.6%
Revenue YoY
9.4%
19.3%
Net Profit YoY
90.3%
42.8%
EPS (diluted)
$1.61
$0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
EZPW
EZPW
Q4 25
$284.0M
$382.0M
Q3 25
$278.6M
$336.8M
Q2 25
$264.6M
$311.0M
Q1 25
$244.3M
$306.3M
Q4 24
$259.6M
$320.2M
Q3 24
$250.4M
$294.6M
Q2 24
$242.0M
$281.4M
Q1 24
$205.8M
$285.6M
Net Profit
ACAD
ACAD
EZPW
EZPW
Q4 25
$273.6M
$44.3M
Q3 25
$71.8M
$26.7M
Q2 25
$26.7M
$26.5M
Q1 25
$19.0M
$25.4M
Q4 24
$143.7M
$31.0M
Q3 24
$32.8M
$15.2M
Q2 24
$33.4M
$17.9M
Q1 24
$16.6M
$21.5M
Gross Margin
ACAD
ACAD
EZPW
EZPW
Q4 25
90.8%
58.4%
Q3 25
92.2%
59.0%
Q2 25
92.2%
59.1%
Q1 25
91.7%
58.3%
Q4 24
91.6%
57.9%
Q3 24
92.5%
59.5%
Q2 24
92.5%
59.2%
Q1 24
88.8%
58.7%
Operating Margin
ACAD
ACAD
EZPW
EZPW
Q4 25
6.1%
15.9%
Q3 25
12.8%
11.0%
Q2 25
12.2%
11.6%
Q1 25
7.9%
11.2%
Q4 24
59.1%
13.1%
Q3 24
12.6%
8.8%
Q2 24
12.6%
7.9%
Q1 24
7.4%
9.6%
Net Margin
ACAD
ACAD
EZPW
EZPW
Q4 25
96.3%
11.6%
Q3 25
25.8%
7.9%
Q2 25
10.1%
8.5%
Q1 25
7.8%
8.3%
Q4 24
55.4%
9.7%
Q3 24
13.1%
5.2%
Q2 24
13.8%
6.4%
Q1 24
8.0%
7.5%
EPS (diluted)
ACAD
ACAD
EZPW
EZPW
Q4 25
$1.61
$0.55
Q3 25
$0.42
$0.35
Q2 25
$0.16
$0.34
Q1 25
$0.11
$0.33
Q4 24
$0.86
$0.40
Q3 24
$0.20
$0.20
Q2 24
$0.20
$0.25
Q1 24
$0.10
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
EZPW
EZPW
Cash + ST InvestmentsLiquidity on hand
$177.7M
$465.9M
Total DebtLower is stronger
$518.6M
Stockholders' EquityBook value
$1.2B
$1.1B
Total Assets
$1.6B
$2.0B
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
EZPW
EZPW
Q4 25
$177.7M
$465.9M
Q3 25
$258.0M
$469.5M
Q2 25
$253.6M
$472.1M
Q1 25
$217.7M
$505.2M
Q4 24
$319.6M
$174.5M
Q3 24
$155.1M
$170.5M
Q2 24
$177.1M
$218.0M
Q1 24
$204.7M
$229.1M
Total Debt
ACAD
ACAD
EZPW
EZPW
Q4 25
$518.6M
Q3 25
$518.1M
Q2 25
$517.6M
Q1 25
$620.5M
Q4 24
$327.7M
Q3 24
$327.3M
Q2 24
$361.3M
Q1 24
$360.9M
Stockholders' Equity
ACAD
ACAD
EZPW
EZPW
Q4 25
$1.2B
$1.1B
Q3 25
$917.3M
$1.0B
Q2 25
$822.4M
$990.1M
Q1 25
$765.2M
$851.6M
Q4 24
$732.8M
$823.9M
Q3 24
$577.2M
$804.6M
Q2 24
$516.7M
$801.5M
Q1 24
$464.0M
$800.4M
Total Assets
ACAD
ACAD
EZPW
EZPW
Q4 25
$1.6B
$2.0B
Q3 25
$1.3B
$2.0B
Q2 25
$1.2B
$1.9B
Q1 25
$1.1B
$1.8B
Q4 24
$1.2B
$1.5B
Q3 24
$976.9M
$1.5B
Q2 24
$914.1M
$1.5B
Q1 24
$855.1M
$1.5B
Debt / Equity
ACAD
ACAD
EZPW
EZPW
Q4 25
0.48×
Q3 25
0.51×
Q2 25
0.52×
Q1 25
0.73×
Q4 24
0.40×
Q3 24
0.41×
Q2 24
0.45×
Q1 24
0.45×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
EZPW
EZPW
Operating Cash FlowLast quarter
$-48.7M
$39.1M
Free Cash FlowOCF − Capex
$31.7M
FCF MarginFCF / Revenue
8.3%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
-0.18×
0.88×
TTM Free Cash FlowTrailing 4 quarters
$121.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
EZPW
EZPW
Q4 25
$-48.7M
$39.1M
Q3 25
$74.3M
$51.3M
Q2 25
$64.0M
$34.8M
Q1 25
$20.3M
$36.9M
Q4 24
$40.4M
$26.0M
Q3 24
$63.2M
$43.3M
Q2 24
$25.0M
$33.7M
Q1 24
$29.1M
$15.1M
Free Cash Flow
ACAD
ACAD
EZPW
EZPW
Q4 25
$31.7M
Q3 25
$73.9M
$35.7M
Q2 25
$25.7M
Q1 25
$28.6M
Q4 24
$20.4M
Q3 24
$63.2M
$24.4M
Q2 24
$30.5M
Q1 24
$8.6M
FCF Margin
ACAD
ACAD
EZPW
EZPW
Q4 25
8.3%
Q3 25
26.5%
10.6%
Q2 25
8.3%
Q1 25
9.3%
Q4 24
6.4%
Q3 24
25.2%
8.3%
Q2 24
10.8%
Q1 24
3.0%
Capex Intensity
ACAD
ACAD
EZPW
EZPW
Q4 25
2.0%
Q3 25
0.1%
4.6%
Q2 25
2.9%
Q1 25
2.7%
Q4 24
1.8%
Q3 24
0.0%
6.4%
Q2 24
1.1%
Q1 24
2.3%
Cash Conversion
ACAD
ACAD
EZPW
EZPW
Q4 25
-0.18×
0.88×
Q3 25
1.03×
1.92×
Q2 25
2.40×
1.31×
Q1 25
1.07×
1.45×
Q4 24
0.28×
0.84×
Q3 24
1.93×
2.85×
Q2 24
0.75×
1.88×
Q1 24
1.76×
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

EZPW
EZPW

Merchandise$210.1M55%
Pawn Service$131.9M35%
Jewelry Scrap$39.9M10%

Related Comparisons